App-Quantinova.ai

OCT-based management of late stent thrombosis: results from the SAFE registry

Catalin Toma - Transcatheter Cardiovascular Therapeutics (TCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results

Stefan Verheye - Transcatheter Cardiovascular Therapeutics (TCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prasugrel In Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The REsponsiveness To CLOpidogrel And StEnt Thrombosis (RECLOSE)- 3 Study

Renato Valenti - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Improving Outcomes and Reducing Costs for Cancer Associated Thrombosis Using a Centralized Service: The Cleveland Clinic Experience

Emma Rabinovich - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Patients with ACS vs. non-ACS: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abhishek Sharma - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Thromboelastography Delineates Hypercoagulation in an Immunocompentent Murine Model of Metastatic Colon Cancer

Theresa Chin - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The Multilayer Flow Modulator Stent For The Treatment Of Thoraco Abdominal And Abdominal Aortic Aneurysms. Moroccan Experience

Michel C. Henry - Transcatheter Cardiovascular Therapeutics (TCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Revascularization strategies for patients with multiple vessel disease and unprotected left main with a cobalt-chromium rapamycin eluting stent (ERACI IV Registry)

Alfredo M. Rodriguez-Granillo - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Rapacan

Novel Anticoagulants for Use in Children

Guy A. Young - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Mechanical abnormalities associated to drug eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry

Nicolas Amabile - Transcatheter Cardiovascular Therapeutics (TCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Thrombotic Complications Are Associated with Phlebotomy Therapy in Patients with Chuvash Polycythemia

Adelina Sergueeva - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Development of a Surveillance System for Hospital-Acquired Pediatric Venous Thromboembolism

Laura H. Brower - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pediatric Venous Thromboembolism Decision Support in the Electronic Medical Record: Identifying Challenges and Best Practices for Implementation

Emily C. Webber - Pediatric Academic Societies (PAS) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Old Saphenous Vein Grafts with important degeneration treated with self-expandable drug-eluting stents: our experience

Cinzia Moncalvo - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: Two Years Follow-up Results from the PATENT-C First in Human Trial

Bruno Scheller - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Cost-Effectiveness Of The Xience Cobalt Chromium Everolimus Eluting Stent Compared With Bare Metal Stents: A United States Payer Perspective

Nicole Ferko - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Role of Red Cells in Thrombosis and Hemostasis

John W. Weisel - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylserine

Clinical Outocomes of Interferon Administration in Combination With Sorafenib in Patients With Recurrent Advanced Hepatits C-Related Hepatocellular Carcinoma

Hisakazu Doi - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Interferon

Higher Prevalence of Portal and Mesenteric Venous Thrombosis in Inflammatory Bowel Disease: A Nationwide Inpatient Sample Study

Won Cho - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?

Alex C. Spyropoulos - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

7277 Abstracts